1 / 25

Headache

Headache. By Wael Hamdy Mansy , MD Assistant Professor of Clinical Pharmacy King Saud University. Primary headaches OR Idiopathic headaches THE HEADACHE IS ITSELF THE DISEASE NO ORGANIC LESION IN THE BEACKGROUND TREAT THE HEADACHE!. Secondary headaches OR Symptomatic headaches

hiero
Télécharger la présentation

Headache

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Headache By WaelHamdyMansy, MD Assistant Professor of Clinical Pharmacy King Saud University

  2. Primary headaches OR Idiopathic headaches THE HEADACHE IS ITSELF THE DISEASE NO ORGANIC LESION IN THE BEACKGROUND TREAT THE HEADACHE! Secondary headaches OR Symptomatic headaches THE HEADACHE IS ON LY A SYMPTOM OF AN OTHER UNDERLYING DISEASE TREAT THE UNDERLYING DISEASE! Classification of headaches

  3. SECONDARY, SYMPTOMATIC HEADACHES • THE HEADACHE IS A SYMPTOM OF AN UNDERLYING DISEASE, LIKE • Hypertension • Sinusitis • Glaucoma • Eye strain • Fever • Cervical spondylosis • Anaemia • Temporal arteriitis • Meningitis, encephalitis • Brain tumor, meningeal carcinomatosis • Haemorrhagic stroke…

  4. Primary, idiopathic headaches • Tension type of headache • Migraine • Cluster headache • Other, rare types of primary headaches

  5. Tension headache • Renamed tension-type headaches by the International Headache Society in 1988, are the most common type of primary headaches. • The pain can radiate from the neck, back, eyes, or other muscle groups in the body. • Tension-type headaches account for nearly 90% of all headaches. Approximately 3% of the population has chronic tension-type headaches

  6. Tension –type headaches can be episodic or chronic. • Episodic tension-type headaches occur 15 days a month. • Chronic tension-type headaches 15 days or more a month for at least 6 months. • Can last from minutes to days, months or even years, though a typical tension headache lasts 4-6 hs

  7. Cluster headache • Nicknamed "suicide headache", is a neurological disease that involves an immense degree of pain. • "Cluster" refers to the tendency of these headaches to occur periodically, with active periods interrupted by spontaneous remissions. • The cause of the disease is currently unknown. It affects approximately 0.1% of the population, and men are more commonly affected than women

  8. Migraine Headache

  9. Prevalence • Familial • Young, healthy women; F>M: 3:1 • 17 – 18.2% of adult females • 6 – 6.5% adult males • 2-3rd decade onset… can occur sooner • Peaks ages 22-55. • ½ migraine sufferers not diagnosed. • 94% of patients seen in primary care settings for headache have migraines

  10. Common misdiagnoses for migraine: • Sinus Headache (HA) • Stress HA • Referral to ENT for sinus disease and facial pain.

  11. The International Headache Society (IHS) classifies migraine headache • The IHS defines the intensity of pain with a verbal, four-point scale:

  12. IHS Diagnostic criteria: migraine w/o aura HA lasting for 4-72 hrs HA w/2+ of following: Unilateral Pulsating Mod/severe intensity. Aggravated by routine physical activity. During HA at least 1 of following N/V Photophobia Phonophobia IHS criteria: Migraine/aura (3 out of 4) One or more fully reversible aura symptoms indicates focal cerebral cortical or brainstem dysfunction. At least one aura symptom develops gradually over more than 4 minutes. No aura symptom lasts more than one hour. HA follows aura w/free interval of less than one hour and may begin before or w/aura. Migraine Definition History, PE, Neuro exam show no other organic disease. At least five attacks occur

  13. Aura Mechanism • Cortical spreading depression • Self propagating wave of neuronal and glial depolarization across the cortex • Activates trigeminal afferents • Causes inflammation of pain sensitive meninges that generates HA through central/peripheral reflexes. • Alters blood-brain barrier. • Associated with a low flow state in the dural sinuses.

  14. Auras • Vision – most common neurologic symptom • Paresthesia of lips, lower face and fingers… 2nd most common • Typical aura • Flickering uncolored zigzag line in center and then periphery • Motor – hand and arm on one side • Auras (visual, sensory, aphasia) – 1 hr • Prodrome • Lasts hours to days…

  15. DURING AURA: VASOCONSTRICTION HYPOPERFUSION DURING HEADACHE VASODILATION HYPERPERFUSION MIGRAINE WITH AURA BUT: AURA SYMPTOM IS NOT CONSEQUENCE OF VASOCONSTRICTION INDUCED HYPOPERFUSION CUASE OF THE AURA: SPREADING DEPRESSION. THE VASOCONSTRICTION AND HYPOPERFUSION ARE CONSEQUENCES OF THE SPREADIND DEPRESSION AURA SPREADING DEPRESSION VASOCONSTRICTION, HYPOPERFUSION

  16. IMPORTANT TO KNOW! MIGRAINE WITH AURA • IS A RISK FACTOR FOR ISCHAEMIC STROKE • THEREFORE PATIENTS SUFFERING FROM MIGRAINE WITH AURA • SHOULD NOT SMOKE!!! • SHOULD NOT USE ORAL CONTRACEPTIVE DRUGS!!! • THE PROPROTION OF PATENT FORAMEN OVALE IN PATIENTS WITH MIGRAINE WITH AURA IS ABOUT 50-55%! (IN THE POPULATION IS ABOUT 25%).

  17. Clinical manifestations • Clinical manifestations • Lateralized in severe attacks – 60-70% • Bifrontal/global HA – 30% • Gradual onset with crescendo pattern. • Limits activity due to its intensity. • Worsened by rapid head motion, sneezing, straining, constant motion or exertion. • Focal facial pain, cutaneous allodynia, GI dysfunction, facial flushing, lacrimation, rhinorrhea, nasal congestion and vertigo…

  18. Precipitating factors • stress • head and neck infection • head trauma/surgery • aged cheese • dairy • red wine • nuts • shellfish • caffeine withdrawal • vasodilators • perfumes/strong odors • irregular diet/sleep • light

  19. Treatment • Abortive • Stepped • Stratified • Staged • Preventive

  20. Abortive Therapy • Reduces headache recurrence. • Alleviation of symptoms. • Analgesics • Tylenol, opioids… • Antiphlogistics • NSAIDs • Vasoconstrictors • Caffeine • Sympathomimetics • Serotoninergics • Selective - triptans • Nonselective – ergots • Metoclopramide

  21. Abortive care strategies • Stepped • Start with lower level drugs, then switch to more specific drugs if symptoms persist or worsen. • Analgesics – Tylenol, NSAIDs… • Vasoconstrictors – sympathomimetics… • Opioids (try to avoid) - Butorphanol • Triptans – sumatriptan (oral, SQ, nasal), naratriptan, rizatripatan, zomatriptan. • Limited by patient compliance. • Stratified • Adjusts treatment according to symptom intensity. • Mild – analgesics, NSAIDs • Moderate – analgesic plus caffeine/sympathomimetic • Severe – opioids, triptans, ergots… • Severe sx treatment limited due to concomitant GI sx’s. • Staged • Bases treatment on intensity and time of attacks. • HA diary reviewed with patient. • Medication plan and backup plans.

  22. Preventive therapy • Consider if pt has more than 3-4 episodes/month. • Reduces frequency by 40 – 60%. • Breakthrough headaches easier to abort. • Beta blockers • Amitriptyline • Calcium channel blockers • Lifestyle modification. • Biofeedback.

  23. Botox 51% migraineurs treated had complete prophylaxis for 4.1 months. 38% had prophylaxis for 2.7 months. Randomized trial showed significant improvement in headache frequency with multiple treatments.

  24. Conclusions • Migraine is common but unrecognized. • Keep migraine and its variants in the differential diagnosis.

  25. References • Landy, S. Migraine throughout the Life Cycle: Treatment through the Ages. Neurology. 2004; 62 (5) Supplement 2: S2-S8. • Bailey, BJ. Head and Neck Surgery – Otolaryngology 3rd Edition. 2001. Pgs. 221-235. • Bajwa, ZH, Sabahat, A. Pathophysiology, Clinical Manifestations, and Diagnosis of Migraine in Adults. Up To Date online. 2005. • Lipton, RB, Stewart, WF, Liberman, JN. Self-awareness of migraine: Interpreting the labels that headache sufferers apply to their headaches. Neurology. 2002; 58(9) Supplement 6: S21-S26. • Cady, RK, Schreiber, CP. Sinus headache or migraine?: Considerations in making a differential diagnosis. Neurology. 2002; 58 (9) Supplement 6: S10-S14. • Perry, BF, Login, IS, Kountakis, SE. Nonrhinologic headache in a tertiary rhinology practice. Otolaryngology – Head and Neck Surg 2004; 130: 449-452. • Daudia, AT, Jones, NS. Facial migraine in a rhinological setting. Clinical Otolaryngology and Allied Sciences. 2002; 27(6): 521-525. • Spierings, EL. Migraine mechanism and management. Otolarynogol Clin N Am 36 (2003): 1063 – 1078. • Avnon, y, Nitzan, M, Sprecher, E, Rogowski, Z, and Yarnitsky, D. Different patterns of parasympathetic activation in uni- and bilateral migraineurs. Brain. 2003; 126: 1660-1670. • Stroud, RH, Bailey, BJ, Quinn, FB. Headache and Facial Pain. Dr. Quinn’s Online Textbook of Otolaryngology Grand Rounds Archive. 2001. http://www.utmb.edu/otoref/Grnds/HA-facial-pain-2001-0131/HA-facial-pain-2001.doc • Ondo, WG, Vuong KD, Derman, HS. Botulinum toxin A for chronic daily headache: a randomized, placebo-controlled, parallel design study. Cephalalgia 2004 (24): 60-65.

More Related